Parkinson's Disease (PD) Drugs Market 2017 Analysis, Growth and Demand Forecast to 2021 By Radiant Insights


Posted September 29, 2017 by MarketResearchReport

Radiant Insights analysts forecast the global parkinson's disease (PD) drugs market to grow at a CAGR of 3.81% during the period 2017-2021.
 
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra. This lowers the concentration of dopamine in the striatum by 80%. This decrease in dopamine levels leads to symptoms associated with PD such as tremors, bradykinesia, and muscular rigidity. It is usually diagnosed after the age of 50 years; however, cases of earlier incidence have also been reported.

Radiant Insights analysts forecast the global parkinson's disease (PD) drugs market to grow at a CAGR of 3.81% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global parkinson's disease (PD) drugs market for 2017-2021. To calculate the market size, the report considers sales/revenues and market share of the PD drugs.

Download Full Research Report @ https://www.radiantinsights.com/research/global-parkinson-s-disease-pd-drugs-market-2017-2021

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Global Parkinson's Disease (PD) Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Boehringer Ingelheim
• GlaxoSmithKline
• Novartis
• Teva Pharmaceutical Industries

Other prominent vendors
• AbbVie
• Abital Pharma
• Addex Therapeutics
• Biogen
• Eisai
• Eli Lilly
• F. Hoffmann-La Roche
• H. Lundbeck
• Impax Laboratories
• Kyowa Hakko Kirin
• Otsuka Pharmaceutical
• Pfizer
• Prana Biotechnology
• Reviva Pharmaceuticals
• SK Biopharmaceuticals
• Takeda Pharmaceutical
• UCB

Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-parkinson-s-disease-pd-drugs-market-2017-2021/request-sample

Market driver
• Rise in geriatric population
• For a full, detailed list, view our report

Market challenge
• Entry of generics
• For a full, detailed list, view our report

Market trend
• Emergence of biomarkers
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Priya Sharma
Phone 1-888-928-9744
Business Address 201 Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Country United States
Categories Health
Tags market research , marketing research , parkinsons disease pd drugs market , parkinsons disease drugs , parkinsons disease drugs market
Last Updated September 29, 2017